Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHR | P35869 | 1/20 | 0.40 |
| ▸ | CES1 | P23141 | 2/20 | 0.40 |
| ▸ | CTSK | P43235 | 1/20 | 0.38 |
| ▸ | MGLL | Q99685 | 1/20 | 0.35 |
| ▸ | DRD4 | P21917 | 2/20 | 0.35 |
| ▸ | BCHE | P06276 | 2/20 | 0.35 |
| ▸ | ACHE | P22303 | 2/20 | 0.35 |
| ▸ | CNR2 | P34972 | 1/20 | 0.34 |
| ▸ | HTR1A | P08908 | 1/20 | 0.34 |
| ▸ | DRD2 | P14416 | 1/20 | 0.34 |
| ▸ | NCEH1 | Q6PIU2 | 1/20 | 0.34 |
| ▸ | DAGLA | Q9Y4D2 | 1/20 | 0.34 |
| ▸ | PRKAA2 | P54646 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17064418 | 1.00 | AHR (0.40) | AHRCES1CTSKMGLLDRD4 | |
| SCHEMBL17073502 | 0.83 | CTSK (0.38) | AHRCES1CTSKMGLLDRD4 | |
| SCHEMBL25784102 | 0.76 | CTSK (0.33) | AHRCES1CTSKMGLLDRD4 | |
| SCHEMBL28719014 | 0.75 | GSK3B (0.46) | AHRCES1DAGLA | |
| SCHEMBL9323548 | 0.75 | AHR (0.46) | AHRCES1DAGLA | |
| SCHEMBL17064920 | 0.73 | CTSK (0.33) | CTSKMGLLDRD4 | |
| SCHEMBL18623209 | 0.73 | CTSK (0.33) | CTSKMGLLDRD4 | |
| SCHEMBL17064922 | 0.73 | CTSK (0.33) | CTSKMGLLDRD4 | |
| SCHEMBL2956687 | 0.73 | AHR (0.49) | AHRCTSK | |
| SCHEMBL29581222 | 0.72 | SMN1; SMN2 (0.56) | CES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113307772-B | Human plasma kallikrein inhibitors | 拜奥克里斯特制药公司 | 2024-06-28 | — | — | CN | disclosed |